Surprisingly, neither cardiac-specific overexpression of wildtype nor the dominant-negative form of Mst1 (suppresses endogenous Mst1) caused any significant changes in cardiac function or cardiac hypertrophy in mice at baseline conditions (Yamamoto et al., 2003; Odashima et al., 2007). Here, MST1 is linked to cardiac hypertrophy.